Daniel Dolan
Keine laufenden Positionen mehr
Karriereverlauf von Daniel Dolan
Ehemalige bekannte Positionen von Daniel Dolan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NABRIVA THERAPEUTICS PLC | Finanzdirektor/CFO | 12.03.2021 | 30.06.2023 |
RADIUS HEALTH, INC. | Comptroller/Controller/Auditor | 24.09.2020 | 15.12.2020 |
Finanzdirektor/CFO | 24.09.2020 | 15.12.2020 | |
Corporate Officer/Principal | 15.12.2020 | 15.01.2021 | |
Treasurer | 24.09.2020 | 15.12.2020 | |
SHIRE | Corporate Officer/Principal | 01.09.2005 | 01.07.2017 |
Ausbildung von Daniel Dolan
Widener University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 3 |
Irland | 3 |
Operativ
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Comptroller/Controller/Auditor | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NABRIVA THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Daniel Dolan
- Erfahrung